glp-1 weight loss drugs competitive analysis leave users low on key nutrients, study finds Comparing Ozempic, Wegovy and Other
Description
Great information, thanks for sharing
When it comes to side effects, the safety profile tells us that some people get common side effects, but these are often mild and can be managed
The primary legal issue could be whether the Ozempic, Wegovy, and Rybelsus manufacturer Novo Nordisk knew or should have known about the heightened risks for gastroparesis/stomach paralysis that these drugs posed to users and failed to warn doctors and patients of this risk
Livingston, R
Importantly, the ban was not sudden
Sometimes GLP-1s that are approved for type 2 diabetes can be prescribed off-label for weight loss
